a16z Capital Management, L.L.C.

Institutional investor · Portfolio as of Q1 2026

Q1 2026 biggest moves
  • GLTOGLTO

    DAMORA THERAPEUTICS

    New

    2.5% of portfolio

  • OMDAOMDA

    Omada Health

    Cut 33%

    now 2.2% of portfolio

  • NAVNNAVN

    Navan

    Added 4%

    now 29% of portfolio

  • FIGFIG

    Figma

    Cut 1%

    now 26% of portfolio

8 changes in all

Top Holdings16 positions

Checking export access…
Activity:
NAVN

Navan, Inc.

28.2M$373.6M28.9%$16.94-21.85%
2 qtrssince 2025-Q4
Increased
Unranked
FIG

Figma, Inc.

16M$338.5M26.2%$51.87-59.24%
3 qtrssince 2025-Q3
Decreased
0
META

Meta Platforms, Inc.

212,531$121.6M9.4%$731.90-21.96%
3 qtrssince 2025-Q3
Unchanged
0
RVMD

Revolution Medicines, Inc.

921,099$89.6M6.9%$28.68+239.09%
10 qtrssince 2023-Q4
Unchanged
0
NAUT

Nautilus Biotechnology, Inc.

17.7M$68.5M5.3%$2.99+29.77%
10 qtrssince 2023-Q4
Unchanged
0
XYZ

Block, Inc.

1M$61.2M4.7%——
10 qtrssince 2023-Q4
Unchanged
0
BIOA

BioAge Labs, Inc.

3.2M$56.5M4.4%$19.78-11.59%
7 qtrssince 2024-Q3
Unchanged
0
MAZE

Maze Therapeutics, Inc.

1.7M$50.8M3.9%$11.01+171.12%
5 qtrssince 2025-Q1
Unchanged
0
ERAS

Erasca, Inc.

2.9M$46.3M3.6%$2.13+659.62%
10 qtrssince 2023-Q4
Unchanged
0
GLTO

DAMORA THERAPEUTICS INC

1.2M$32M2.5%$25.900.00%
1 qtr
New
78
OMDA

Omada Health, Inc.

2.3M$29M2.2%$18.30-31.31%
4 qtrssince 2025-Q2
Decreased
0
CAMP

CAMP4 Therapeutics Corporation

2.1M$9.4M0.7%$5.22-15.52%
6 qtrssince 2024-Q4
Unchanged
0
AKTS

Aktis Oncology, Inc.

415,000$7.4M0.6%$17.890.00%
1 qtr
New
56
BTGO

BitGo Holdings, Inc.

666,356$5.5M0.4%$8.230.00%
1 qtr
New
48
DNA

Ginkgo Bioworks Holdings, Inc.

108,568$665,5220.1%$8.15-24.79%
7 qtrssince 2024-Q3
Unchanged
0
IPST

IP Strategy Holdings, Inc.

82,740$21,8430.0%$5.28-55.49%
1 qtr
New
29
$1.3B
AUM
16
Positions
Q1 2026
Filing
HI rating · 2.5/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2024-Q4$745,255,646-34.4997461615%
2025-Q1$700,872,513-5.95542391906%
2025-Q2$312,909,254-55.3543264722%
2025-Q3$1,394,890,890345.781283925%
2025-Q4$1,579,784,57813.2550645592%
2026-Q1$1,290,612,468-18.3045279734%
Activity profile
$ moved · Q1'26
New10%Increased21%Decreased68%Exited<1%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.5 years
<1Q25%1-4Q6%1-2Y13%2Y+56%

a16z Capital Management, L.L.C. manages $1.3B across 16 positions as of Q1 2026. Top holdings: NAVN (28.9%), FIG (26.2%), META (9.4%). Fund DNA: High Conviction Activist. HoldingsIntel Score: 2.5/5.0.

Top holdings by portfolio weight

Total AUM$1B
NAVN28.95%
FIG26.23%
META9.42%
RVMD6.94%
NAUT5.31%
XYZ4.74%
BIOA4.38%
MAZE3.94%
ERAS3.59%
GLTO2.48%
Other2.25%

Portfolio allocation by GICS sector

Sectors4
Technology60.52%
Healthcare29.96%
Communication Services9.52%
Financial Services0.00%

Behavioral investing profile

Checking access…
High Conviction Activist- primarily Technology, Healthcare
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(2.5 / 5.0)
Holdings P&L38
Conviction63
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Photo credits

Photo:“Warren Buffett at the 2015 SelectUSA Investment Summit”by USA International Trade Administration, cropped,public domainvia Wikimedia Commons

Photo:Leopold Aschenbrenner

Photo:“Cathie Wood ARK Invest Photo”by Caroline Wood, cropped,CC BY-SA 4.0via Wikimedia Commons

Photo:“Valeant Pharmaceuticals' Business Model (headshot)”by Senate Democrats, cropped,CC BY 2.0via Wikimedia Commons

Photo:Harlem Children's Zone

Photo:Mohnish Pabrai

Photo:“Peter Thiel on March 5 2026”by Kantei (The Prime Minister Office of Japan), cropped,CC BY 4.0via Wikimedia Commons

Photo:Charlotte FC

Photo:Ray Dalio

Photo:Himalaya Capital

Photo:Jonathan Kozowyk, Robin Hood

Photo:“Brad Gerstner at the White House 2025 (54581192563)”by The White House, cropped,public domainvia Wikimedia Commons

Photo:SuperReturn North America

Photo:Liz Linder, Harvard Kennedy School

Photo:Oaktree Capital Management

Photo:The Everglades Foundation

Photo:George Soros

Photo:Benjamin Meaker, Point72

Photo:Fundsmith

Photo:“Kenneth C. Griffin photo”by Paul Elledge, cropped,CC BY-SA 4.0via Wikimedia Commons

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used